Vincenzo Palermo

Leading Pharma Exec, biotech investor, passionate for making innovation accessible, tweeting on my own.

[Charles Jiang MD, MPH @CharlesJiangMD]

1/ #ASCO26 starts tomorrow. By Friday your feed will be full of survival curves, and the temptation will be everywhere: cross-trial/study comparison.

Before you do so, A few caveats worth keeping in mind

[Vincenzo Palermo @vincepalermo]

@FCademartiri Sono quasi 20 anni che #Jupiter è stato pubblicato e ci stupiamo ancora che ridurre C-LDL non basta ? https://t.co/WzTjnChWnu

[ViiV Healthcare @ViiVHC]

For some people living with #HIV, self-stigma is one of many challenges in managing their health. But HIV care is evolving.
Prof. Antonella Castagna shares how personal choice and tailored options are reshaping HIV care.

👉Read the ViiV sponsored article: https://t.co/pgl6LmIvc7

[European Society of Cardiology Journals @ESC_Journals]

New in #EJPC:
✅ In statin-treated patients with well-controlled LDL-C undergoing percutaneous coronary intervention, residual inflammatory risk (alone or in combination with residual triglyceride risk) is associated with a higher incidence of MACE.
📕 https://t.co/XisgvMVXyG

#EJPC @EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @SMosteoru @TimKambic #cvprev

[Jia (Jenny) Liu MD PhD @JiaJennyLiu]

TIGIT showed us this:
scale without biological precision is expensive noise.

ADC trial activity is accelerating globally.
But patient selection hasn’t evolved.

We’re building a high-speed system
on a low-resolution biomarker framework.

[Troll Football @TrollFootball]

Respect Italy ✊

[𝗧𝗶𝗺𝗲𝗹𝗲𝘀𝘀 𝗠𝘂𝘀𝗶𝗰 ✨🎵 @Hoang_HQ]

Lady Gaga performed Elton John’s “Your Song” in front of him and absolutely nailed it. A perfect moment of pure respect and friendship between two icons. ✨ #LadyGaga #EltonJohn

[AMIMC VIH @AmimcV16801]

Estamos a 9 días de nuestro evento para discutir las novedades en investigación de #CROI2025. Te esperamos. Inscríbete en: https://t.co/ueDpsVwohv

[Wim Vandevelde, @wimvandevelde.bsky.social @VandeveldeWim]

#CROI study: "South Africa, the country that buys 20% of the world’s #PrEP, should not accept a #lenacapavir price higher than $225 per year (or $59 per injection)."

https://t.co/kcbqm8U3WZ https://t.co/ohrLr1opuc

[Carlos del Rio @CarlosdelRio7]

A sobering analysis presented by Andrew Hill at #CROI2026 suggests PrEP is making little to no impact on HIV incidence because in most counties there is < 1 person on PrEP per new infection. PrEP has been such a missed opportunity!

[European Commission @EU_Commission]

One port, one cable, one Europe.

This holiday, unwrap the power of one: USB-C for all.

Yes, not just phones, tablets, and laptops. In three years, every charger will be under the same tree.

Because less waste, smarter choices, mean more for everyone, all year long.

https://t.co/idDzXhlRRn

[Vincenzo Palermo @vincepalermo]

@ArchilocoFe1983 @pisto_gol Non hai nemmeno capito di cosa si parla !

[Manifest_Lord @Manifest_Lord]

13 decisions you need to make by 45 to not regret life.. MUST READ 🧵

[Vincenzo Palermo @vincepalermo]

@loriwastaken @DiMarzio @sscnapoli Ma andato cosa !? Ma non vedi quanti infortuni ?

[Investing visuals @InvestingVisual]

All eyes on $NVDA's Q3 earnings tomorrow!

• Estimated revenue: $55B (+57%)
• Estimated EPS: $1.25 (+55%)

[History Nerd @_HistoryNerd]

In 1860, a French explorer hacked through the Cambodian jungle and uncovered Angkor Wat.

A city larger than medieval London, built by god-kings and powered by advanced engineering.

Yet within a century, it was abandoned to the wild.

Here's the untold story:

[Oncology Brothers @OncBrothers]

2024 approvals: Summary of 8 new drugs/indications in #BreastCancer & #GynOnc by @US_FDA

1. #Ribociclib
2. #Inavolisib
3. #Pembrolizumab x2
4. #Mirvetuximab
5. #Tisotumab
6. #Dostarlimab
7. #Durvalumab

#bcsm #gyncsm #OncTwitter #MedTwitter #HappyHolidays

[Roger Wang @RogerWang11]

The BlackBerry story is a cautionary tale.

1. Innovation waits for no one—touchscreen tech already existed, but BlackBerry ignored it.

2. Never underestimate your competition. The iPhone turned out to be a revolution.

3. Loyalty fades fast if you don't evolve.